Application 210002
- Type
- ANDA
- Sponsor
- INDOCO REMEDIES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALOGLIPTIN | ALOGLIPTIN BENZOATE | TABLET;ORAL | 6.25MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alogliptin | ALOGLIPTIN | Padagis Israel Pharmaceuticals Ltd | b25f155a-1259-47c2-aa3b-7c1356e4c7f6 | 2025-04-11 | Warnings, Adverse reactions | Alogliptin |
| Alogliptin | ALOGLIPTIN | Bryant Ranch Prepack | f2ad6d21-8060-42c7-8b3f-ad80085dc022 | 2025-01-28 | Warnings, Adverse reactions | Alogliptin |
| Alogliptin | ALOGLIPTIN | A-S Medication Solutions | 38d30e4f-4212-4f7a-96b5-74b277b56cba | 2023-10-24 | Warnings, Adverse reactions | Alogliptin |
| Alogliptin | ALOGLIPTIN | Aphena Pharma Solutions - Tennessee, LLC | 4b007011-547a-498e-b8f6-34ea4ea00eb4 | 2023-02-02 | Warnings, Adverse reactions | Alogliptin |
| Alogliptin | ALOGLIPTIN | Aphena Pharma Solutions - Tennessee, LLC | a05d6d17-79f9-4788-a4d5-467bca1a2d91 | 2022-10-18 | Warnings, Adverse reactions | Alogliptin |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 61477 | ORIG | 2019-12-30 |